Immunohistochemical expression of p-Akt, p-mTOR, and p-4EBP1 proteins was examined to determine the pathological role of ChREBP in NASH-related HCC development. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatohepatitis.